Avidity Biosciences Inc (RNA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $72.80
• Market Cap: $11.25B
• EPS: $-4.19
• 52-Week High: $73.06
• 52-Week Low: $21.51

Market Sentiment

Avidity Biosciences Inc currently has a Bullish sentiment score of 0.19.

About Avidity Biosciences Inc

Avidity Biosciences, Inc. (RNA) is a pioneering biopharmaceutical company based in La Jolla, California, focused on advancing innovative oligonucleotide-based therapies for the treatment of a range of serious diseases, including rare genetic disorders. Leveraging its proprietary Avidity platform, the company aims to create targeted RNA therapeutics that enhance the delivery and efficacy of therapeutic agents. With a robust pipeline of candidates in various stages of development, Avidity is po...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Avidity Biosciences Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RNA pay dividends?

Avidity Biosciences Inc (RNA) does not currently pay a regular dividend.

What is RNA's market cap?

Avidity Biosciences Inc (RNA) has a market capitalization of $11.25B with a current stock price of $72.80.